Matthew B. Palmer - Concepedia

Author

Matthew B. Palmer

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Angela T. Moles, M. B. Palmer, M.B Palmer, M.B. Palmer, Matthew B Palmer, Matthew B. Palmer, Matthew Palmer, Mayah Palmer

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of Pennsylvania Hospital of the University of Pennsylvania National Institutes of Health Washington University in St. Louis

About

Matthew B. Palmer is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	1.8K
2	Health Sciences	9	9	607
3	Engineering	1	1	16
4	Language Studies	1	1	23
5	Natural Sciences	1	1	10

Matthew B. Palmer

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice Pazit Beckerman, Jing Bi‐Karchin, Ae Seo Deok Park, Nature Medicine UrologyRenal FunctionMedicineKidney FailureImmunology	2017	341
Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stains Catherine Jayapandian, Yijiang Chen, Andrew Janowczyk, Kidney International	2020	190
Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration Michael S. Balzer, Tomohito Doke, Ya‐Wen Yang, Nature Communications	2022	172
Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice Steven J. Frank, James D. Cox, Michael T. Gillin, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNeuro-oncologyRadiation TherapyGliomaMedicine	2014	150
Intensity-Modulated Proton Therapy Further Reduces Normal Tissue Exposure During Definitive Therapy for Locally Advanced Distal Esophageal Tumors: A Dosimetric Study James W. Welsh, Daniel R. Gomez, Matthew B. Palmer, International Journal of Radiation OncologyBiologyPhysics Definitive TherapySurgical OncologyRadiation MedicineEsophagusRadiation Therapy	2011	137
A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits Ramnika Gumber, Jordana B. Cohen, Matthew B. Palmer, Kidney International Glomerular DiseaseImmunologyPathologyMonoclonal Immunoglobulin DepositsGlomerulonephritis	2018	133
The key role of NLRP3 and STING in APOL1-associated podocytopathy Junnan Wu, Archana Raman, Nathan J. Coffey, Journal of Clinical Investigation Key RoleImmunologyRenal InflammationPathologyCell Death	2021	128
Proteasome inhibitor associated thrombotic microangiopathy Jennifer Yui, Jan Van Keer, Brendan M. Weiss, American Journal of Hematology Proteasome InhibitorsPathologySuspected TmaPharmacotherapyHematological Malignancy	2016	112
Esophageal Cancer Dose Escalation Using a Simultaneous Integrated Boost Technique James W. Welsh, Matthew B. Palmer, Jaffer A. Ajani, International Journal of Radiation OncologyBiologyPhysics EsophagusEsophageal CancerMedicineSurgeryOncology	2010	104
Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes Sarah McAvoy, Katherine Ciura, Caimiao Wei, International Journal of Radiation OncologyBiologyPhysics Proton Beam TherapyRadiation TherapyMedicineProton TherapyDefinitive Reirradiation	2014	88

Page 1